13
BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

Embed Size (px)

Citation preview

Page 1: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

BMPR1ABone Morphogenetic Protein Receptor 1 A

(Juvenile Polyposis & Colon Cancer)

Hallie Wieters

Page 2: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

BMPR1A is part of a TGF-βReceptor Serine/Threonine Kinase

Page 3: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

There are multiple ligands, receptors and many

SMADs

Page 4: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

BMPs can regulate cell differentiation, growth inhibition

or apoptosis

Page 5: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

KO BMPR1-A mutant mouse

leads to embryonic lethality due to

failed gastrulation

Page 6: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

Continual loss of intestinal cells and repetitive cell cycle entry causes the

colon to be prone to mutations

Page 7: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

Juvenile Polyposis leads to colon polyp formation and thus a predisposition to

colon cancer

Page 8: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

Juvenile Polyposis is caused by germline mutations and loss of heterozygosity at BMPR1-A loci

Page 9: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

Mutated BMPR1-A leads to increased proliferation, decreased

differentiation, increased number of stem cells and cell persistence

Page 10: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

Scientists have created a mouse model of juvenile polyposis by

mutating BMPR1-A

Page 11: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

Juvenile Polyposis can be diagnosed through genetic screening and treated

through colon surveillance

Page 12: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

SummaryBMPR1A is a threonine/serine kinase receptor in the

TGF-βfamily (growth-inhibitorytumor suppressor)

Germline Mutations cause a nonfunctional receptor leading to propagation of proliferating signals and an increase stem cells

Inherited autosomal dominantly recessive at the cellular level

Lack of regulation in proliferation leads to development of polyps in the colon Juvenile Polyposis

Page 13: BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters

ReferencesHe, X. C., Zhang, J., Tong, W.-G., Tawfik, O., Ross, J., Scoville, D. H., Tian, Q., Zeng, X., He, X., Wiedemann, L. M., Mishina, Y., Li, L. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nature Genet. 36: 1117-1121, 2004.Cichy, Wojciech, Beata Klincewicz, and Andrzej Plawski. “Juvenile Polyposis Syndrome.” Archives of

Medical Science : AMS 10.3 (2014): 570–577. PMC. Web. 2 Mar. 2015.Mishina, Yuji,Suzuki, A., Ueno, N., Behringer, R. Bmpr encodes a type 1 bone morphogenetic protein

receptor that is essentail for gastrulation during mouse embryogenesis. Genes & Development, 9

(1995): 3027-3037. Waite, Kristen, Eng, C., From developmental disorder to heritable cancer : It’s all in the TGF-B

Family. Nature Reviews: Genetics. 4 (2003) : 763-772.

Zhou, Xiao-Ping et al. “Germline Mutations in BMPR1A/ALK3 Cause a Subset of Cases of Juvenile Polyposis Syndrome and of Cowden and Bannayan-Riley-Ruvalcaba Syndromes.” American Journal of Human Genetics 69.4 (2001): 704–711. Print.

Chen, Di, Mundy, G. “Bone Morphogenetic Proteins”. Growth Factors 22 (2004):233-241